Clinical Trial Update: A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing SB4, a biosimilar to etanercept, with Enbrel in adults with moderate-to-severe rheumatoid arthritis on methotrexate completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• SB4 (etanercept biosimilar)

Snippet

Sponsor: Samsung Bioepis Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2016-08-29